Evidence map›Paper›PMID 34335130›Full record

ArticleAdvanced synthesis & catalysis2021

Selectivity in the Elaboration of Bicyclic Borazarenes.

Ayan Bhattacharjee, Geraint H M Davies, Borna Saeednia, Steven R Wisniewski, Gary A Molander

Abstract read
In one paragraph

Article in Advanced synthesis & catalysis, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. The Rise of 1,4-BN-Heteroarenes: Synthesis, Properties, and Applications.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ayan BhattacharjeeRoy and Diana Vagelos Laboratories, Department of Chemistry, University of Pennsylvania, 231 South 34th Street, Philadelphia, Pennsylvania 19104-6323, United States.ORCID 0000-0001-7665-5554
Geraint H M DaviesSmall Molecule Drug Development, Bristol Myers Squibb Company, 200 Cambridge Park Drive, Cambridge, Massachusetts 02140, United States.ORCID 0000-0002-5986-0756
Borna SaeedniaRoy and Diana Vagelos Laboratories, Department of Chemistry, University of Pennsylvania, 231 South 34th Street, Philadelphia, Pennsylvania 19104-6323, United States.ORCID 0000-0003-2756-7827
Steven R WisniewskiChemical Process Development, Bristol Myers Squibb Company, One Squibb Drive, New Brunswick, New Jersey 08903, United States.ORCID 0000-0001-6035-4394
Gary A MolanderRoy and Diana Vagelos Laboratories, Department of Chemistry, University of Pennsylvania, 231 South 34th Street, Philadelphia, Pennsylvania 19104-6323, United States.ORCID 0000-0002-9114-5584

Funding

Novel Organoboron Chemistry Utilizing TetrahydroxydiboraneR01GM081376 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI MOLANDER, GARY A · 2007 to 2015
$2.6M
Accessing New Chemical Space via Organic SynthesisR35GM131680 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI MOLANDER, GARY A · 2019 to 2022
$2.4M
Novel Borazines: Syntheses and ElaborationR01GM111465 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI MOLANDER, GARY A · 2015 to 2018
$1.0M
NIGMS NIH HHS R01 GM081376NIGMS NIH HHS R01 GM111465NIGMS NIH HHS R35 GM131680
6 · The paper itself

Abstract

Among aromatic compounds, borazarenes represent a significant class of isosteres in which carbon-carbon bonds have been replaced by B-N bonds. Described herein is a summary of the selective reactions that have been developed for known systems, as well as a summary of computationally-based predictions of selectivities that might be anticipated in reactions of yet unrealized substructures.

Indexed as

BicyclicsBorazarenesComputationsIsosteresSelectivity

Identifiers

PMID34335130
PMCPMC8323665

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.